15 Successful Spin-Off Companies and Their 2025 Returns

Page 9 of 13

5. Solventum Corporation (NYSE:SOLV)

Year to Date Return as of July 7: 19.07%

Number of Hedge Fund Holders: 38

Year of Spin-off: 2024

Solventum Corporation (NYSE:SOLV) is one of the 15 successful spin-off companies. On July 1, analysts at Argus Research upgraded the company to a ‘Buy’ from a Hold.’ The analysts also reiterated a $90 price target on the stock. The adjustment comes amid growing confidence that the company is enjoying robust growth.

The upgrade underscores Argus Research’s confidence in Solventum Corp’s ability to execute its long-range plan. The firm expects the company to achieve its margin and revenue targets. In addition, the research firm cited the company’s higher-margin business as one of the reasons behind the upgrade.

Consequently, the research firm has raised its adjusted earnings estimate for the company’s 2026 fiscal year from $5.95 to $5.98 per share. In the first quarter of 2025, Solventum achieved top-line results with robust revenue of $8.3 billion and a solid gross margin of 54.9%.

Solventum Corporation (NYSE:SOLV) is a global healthcare company that was formed following a spin-off from the 3M healthcare business. It develops, manufactures, and commercializes solutions that leverage material science, data science, and digital capabilities to improve healthcare.

Page 9 of 13